|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/506 | |
| A61K 31/428 | |||
| A61K 31/337 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61K 31/505 |
| (11) | Number of the document | 3236966 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15874331.0 |
| Date of filing the European patent application | 2015-12-22 | |
| (97) | Date of publication of the European application | 2017-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/067462 |
| Date | 2015-12-22 |
| (87) | Number | WO 2016/106359 |
| Date | 2016-06-30 |
| (30) | Number | Date | Country code |
| 201462096020 P | 2014-12-23 | US | |
| 201562242629 P | 2015-10-16 | US |
| (72) |
BOZON, Viviana, US
GALVIN, Katherine M., US
BRAKE, Rachael L., US
XU, Qunli, US
KANNAN, Karuppiah, US
|
| (73) |
DOT Therapeutics-1, Inc.,
2765 Sand Hill Road, Menlo Park, CA 94025,
US
|
| (54) | COMBINATION OF RAF INHIBITORS AND TAXANES |
| COMBINATION OF RAF INHIBITORS AND TAXANES |